The Challenges of Genomics Data for Rare Disease Patients
Niyati Parikh, Vice President, Clinical Solutions
.jpg)
ISPOR 2023: A Focus on Quality
Todd Somsel, Commercial Lead, RWD Marketplace The acceptance and application of real-world evidence...
.jpg)
Reuters Pharma 2023: The Promise and Limitations of RWD
Todd Somsel, Commercial Lead, RWD Marketplace As I reflect on the 2023 edition of the Reuters...
How RWD Marketplaces Help Solve Pharma’s Top 10 Challenges to Gathering Actionable Data
A major step in the process of launching a new drug is compiling and analyzing various real-world...
Plan, Activate, and Optimize Precision HCP Marketing
Without the proper support to know how, when, and where to reach HCPs, it can be challenging to...
How to use RWD for provider engagement: 3 pharma best practices
During a recent panel discussion at Reuters Events Pharma Marketing USA, leading pharma executives...
3 reasons it’s time to shift the paradigm for real world data in pharma
Patient-level, real-world data (RWD) in pharma has been used for years to inform drug development...
AI-driven risk prediction: A powerful underwriting tool in an era of high inflation
Anyone who has purchased groceries or filled up at a gas station recently has felt the pinch of...
Prevent drug launch failure with an end-to-end RWD solution
Wall Street expectations and enthusiasm have been high surrounding the biotechnology and...
3 Steps to Faster Patient Journey Mapping for Pharma Brand Success
Understanding the longitudinal patient journey — from symptoms to testing, to diagnosis and...